Cornerstone Pharmaceuticals logo

Cornerstone Pharmaceuticals

Rare Science. Rare Compassion. Rare Solutions.

VS
PrognosDx Health logo

PrognosDx Health

Pioneering the future of cancer diagnostics through advanced epigenetic testing and innovative histone biomarkers.

Side-by-Side Comparison

Metric Cornerstone Pharmaceuticals PrognosDx Health
Founded 2001 2008
Headquarters Cranbury, United States Palo Alto, United States
Employees 11 2-10
Industry Biotechnology, Pharmaceutical Biotechnology, Health Care, Medical Devices
Funding Stage Not tracked yet Debt Financing
Total Funding Not tracked yet $10.00K
Funding Rounds Not tracked yet 1
Business Model Not tracked yet Not tracked yet
Revenue Model Not tracked yet Not tracked yet
Services Not tracked yet Not tracked yet
Target Customers Not tracked yet Not tracked yet
Taxonomy Metabolic Oncology, Therapeutics, Cancer Treatment, Drug Development, Clinical-stage Company, Bio-energetic Processes, Altered Cancer Metabolism, Novel Drugs, Drug Delivery Technologies, Anti-cancer Agents, Clinical Studies, Mitochondria Targeting, Rare Cancers, Devimistat, Mitochondrial Disruption Epigenetics, Cancer Diagnostics, Histone Biomarkers, Prostate Cancer, Pharmaceutical Research, Clinical Sample Analysis, Cancer Prognostic Assays, Therapeutic Response Prediction, Research Tools, Palo Alto, Tissue-based Global Cellular Histone Biomarkers
Website cornerstonepharma.com prognosdx.com
Cornerstone Pharmaceuticals logo

About Cornerstone Pharmaceuticals

Cornerstone Pharmaceuticals is a clinical-stage biotechnology startup that focuses on developing metabolic oncology therapeutics for hard-to-treat cancers. The company's slogan "Rare Science. Rare Compassion. Rare Solutions." emphasizes its dedication to addressing the unique needs of patients with...

PrognosDx Health logo

About PrognosDx Health

PrognosDx Health is a biotechnology company that is pioneering the future of cancer diagnostics through advanced epigenetic testing and innovative histone biomarkers. Specializing in developing and commercializing epigenetic tests focusing on histone modification patterns, the company offers service...

Frequently Asked Questions

Cornerstone Pharmaceuticals — Rare Science. Rare Compassion. Rare Solutions.. PrognosDx Health — Pioneering the future of cancer diagnostics through advanced epigenetic testing and innovative histone biomarkers.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cornerstone Pharmaceuticals has raised undisclosed funding while PrognosDx Health has raised $10.00K.
Cornerstone Pharmaceuticals and PrognosDx Health operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Track both companies in real time

Signal Tracker monitors Cornerstone Pharmaceuticals, PrognosDx Health, and millions of companies for 40+ signal types.

One analytics cookie (Google Analytics). Cookie Policy